Renal complications in oncohematologic patients.
The aim of the present paper was to review recent developments in the management of patients with acute kidney injury or chronic kidney disease occurring secondary to either cancer itself or its therapy, with a focus on infiltration of the renal parenchyma, myeloma, tumor lysis syndrome, glomerular disease, thrombotic microangiopathy, chemotherapy-associated thrombotic microangiopathy, biphosphonate-induced renal diseases, acute kidney injury, and chronic kidney disease after hematopoietic cell transplantation. Further studies are awaited because a better knowledge of renal complications, which frequently occur in patients with oncohematologic diseases, would be conducive to making an early diagnosis and providing prompt therapy.
Buemi
Michele
M
Department of Internal Medicine, University of Messina, Messina, Italy. buemim@unime.it
Fazio
Maria Rosaria
MR
Bolignano
Davide
D
Coppolino
Giuseppe
G
Donato
Valentina
V
Lacquaniti
Antonio
A
Mondello
Stefania
S
Buemi
Antoine
A
Allegra
Alessandro
A
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006402:Hematologic Diseases / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D000970:Antineoplastic Agents